Helena Bejr-Kasem

instituto de salud carlos iii

H指数:14

被引数:734

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson’s disease patients

脑源性细胞外囊泡蛋白质组学揭示血管紧张素II受体拮抗剂坎地沙坦在帕金森病患者中诱导的神经保护作用

npj Parkinson's Disease

IF8.2

2025-12-100

OAAI

Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases

巴塞罗那进行性核上性麻痹（PSP）登记研究：从疑似病例到确诊病例的临床、眼动和脑脊液标志物

Movement Disorders

IF7.6

2025-10-290

PRE

Celia Painous MD, PhD; Manel Fernández MSc; Ana Cámara BSN, MSc; Salut Alba-Arbalat PhD; Marta Soto PhD; Carla Brenlla MD; Esteban Muñoz MD, PhD; Alexandra Pérez-Soriano MD, PhD; Francesc Valldeoriola MD, PhD; Maria J. Martí MD, PhD; Eduard Tolosa MD, PhD; Alicia Garrido MD, PhD; Almudena Sánchez-Gómez MD, PhD; Laura Maragall BA; Anna Camós-Carreras MD; Montse Tió MD, PhD; Nuria Martín MD; Misericordia Basora MD, PhD; Mariateresa. Buongiorno MD, PhD; Maria C. Pont-Sunyer MD, PhD; Tania Delgado MD; Anna Planas-Ballvé MD, PhD; Nuria Caballol MD; Asunción Ávila MD, PhD; Dolores Vilas MD, PhD; Serge Jaumà MD, PhD; Carla Marco MD; Oriol de Fàbregues MD, PhD; Nuria Matos MD; Anna Mas MD; Natàlia Mas MD; Josep M. Aragonés MD; Helena Bejr-Kasem MD, PhD; Judith Navarro-Otano MD, PhD; Elisabet Montori-Palacín MD, PhD; Mircea Balasa MD, PhD; Jordi Sarto MD; Sergi Borrego-Écija MD, PhD; Pedro Roldán MD, PhD; Andrés Perissinotti MD, PhD; Laura Molina-Porcel MD, PhD; Iban Aldecoa MD, PhD; Jessica Pérez-Montesino MSc; Lorena de Mena MD, PhD; Laura Naranjo PhD; Raquel Ruiz-García PhD; Yaroslau Compta MD, PhD

Parkinson disease psychosis: from phenomenology to neurobiological mechanisms

NATURE REVIEWS NEUROLOGY

IF33.1

2024-01-154

PRE

Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION

IF4

2024-01-112

PRE

A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease

PARKINSONISM & RELATED DISORDERS

IF3.4

2023-05-013

PRE

Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease

PARKINSONISM & RELATED DISORDERS

IF3.4

2022-12-0112

PRE

Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers

ANNALS OF NEUROLOGY

IF7.7

2022-09-098

The role of attentional control over interference in minor hallucinations in Parkinson's disease

注意控制对帕金森病轻微幻觉干扰的作用

PARKINSONISM & RELATED DISORDERS

IF3.4

2022-09-012

PRE

Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease

JOURNAL OF THE NEUROLOGICAL SCIENCES

IF3.2

2022-03-0121

OAAI

Sampedro, Federic; Martinez-Horta, Saul; Horta-Barba, Andrea; Grothe, Michel J.; Labrador-Espinosa, Miguel A.; Jesus, Silvia; Adarmes-Gomez, Astrid; Carrillo, Fatima; Puig-Davi, Arnau; Lora, Florinda Roldan; Barbera, Miquel Aguilar; Pastor, Pau; Arroyo, Sonia Escalante; Vila, Berta Solano; Foraster, Anna Cots; Martinez, Javier Ruiz; Padilla, Francisco Carrillo; Morlans, Mercedes Pueyo; Aramburu, Isabel Gonzalez; Ceberio, Jon Infante; Vara, Jorge Hernandez; de Fabregues-Boixar, Oriol; de Deus Fonticoba, Teresa; Avila, Asuncion; Martinez-Castrillo, Juan Carlos; Bejr-Kasem, Helena; Campolongo, Antonia; Pascual-Sedano, Berta; Martinez-Martin, Pablo; Santos-Garcia, Diego; Mir, Pablo; Kulisevsky, Jaime

Neural signatures of predictive language processing in Parkinson's disease with and without mild cognitive impairment

CORTEX

IF3.3

2021-08-016

OAAI

Robot-induced hallucinations in Parkinson's disease depend on altered sensorimotor processing in fronto-temporal network

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2021-04-2831